EMA Authorised: ProQuad (virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella) — Merck Sharp & Dohme B.V.

View source ↗

Summary

EMA has authorized ProQuad, a live attenuated vaccine that protects against varicella (chickenpox), measles, mumps and rubella in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Status: Authorised. Therapeutic area: Chickenpox;Rubella;Measles;Mumps;Immunization. MAH: Merck Sharp & Dohme B.V.. Decision date: 24/09/2025